Femlyv Kit
NDC Package 72495-601-28
Package Information
Femlyv (norethindrone acetate/ethinyl estradiol) kits is fEMLYV is indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14)].Limitations of UseThe efficacy of FEMLYV in females with a body mass index (BMI) of more than 35 kg/m2 has not been evaluated. This formulation utilizes a kit delivery system. Marketed by Millicent Us, Inc., this product is identified by NDC 72495-601 and is authorized under FDA application NDA218718.
Identification & Billing
- RxCUI: 2696883 - ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet
- RxCUI: 2696883 - ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Disintegrating Oral Tablet
- RxCUI: 2696886 - inert ingredients 1 MG Disintegrating Oral Tablet
- RxCUI: 2696887 - {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet) / 4 (inert ingredients 1 MG Disintegrating Oral Tablet) } Pack
- RxCUI: 2696887 - ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72495 - Millicent Us, Inc.
- 72495-601 - Femlyv
- 72495-601-28 - 1 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
- 72495-601 - Femlyv
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72495-601). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72495-601-28 identifies a specific commercial package of 1 pouch in 1 carton / 1 blister pack in 1 pouch / 1 kit in 1 blister pack of Femlyv, a human prescription drug labeled by Millicent Us, Inc.. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Millicent Us, Inc. on November 01, 2024. The current certification is valid through December 31, 2026.
How is this Millicent Us, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72495060128. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.